Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions

Charles T Nakar, MD, Joseph M Parker, MD, Neelam Thakral, Brandon M. Hardesty, MD, Gary Albert, Pierre Laurin, MSc, BPharm, John Moran, MD, Per Morten Sandset, MD PhD, Amy D. Shapiro, MD

Blood (2017) 130 (Supplement 1): 84.

https://doi.org/10.1182/blood.V130.Suppl_1.84.84

Published: 2017

Journal Articles

Safety & Efficacy of Human Plasma Derived Plasminogen Ophthalmic Drops for Treatment of Ligneous Conjunctivitis: Report of Phase 2/3 Clinical Trial

Charles T Nakar, MD, Roberto Caputo, MD, Francis W Price, Jr., MD, Maria Teresa Sartori, MD, Andrea Leonardi, Anna Lotti Suffredini, Neelam Thukral, Jacopo Secci, Bennie H Jeng, MD, Amy D Shapiro, MD

Blood (2015) 126 (23): 2288.

https://doi.org/10.1182/blood.V126.23.2288.2288

Published: 2015

Journal Articles

Prompt Immune Tolerance Induction at Inhibitor Diagnosis Regardless of Titer May Increase Overall Success in Hemophilia A With Inhibitors: Experience of Two US Centers

Charles T Nakar, MD, Marilyn J. Manco-Johnson, MD, Alice Lail, MPH, Sharyne M. Donfield, PhD, Jennifer Maahs, MSN PNP, Young Chong, RN, Taylor A Blades, BS, Amy D. Shapiro, MD

Blood (2013) 122 (21): 575.

https://doi.org/10.1182/blood.V122.21.575.575

Published: 2013

Journal Articles

3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP. (Summary of 2 Pilot Studies).

Charles T Nakar, MD, James B. Bussel, MD

Blood (2009) 114 (22): 2404.

https://doi.org/10.1182/blood.V114.22.2404.2404

Published: 2009

Journal Articles

Recombinant Activated Factor VII (rFVIIa) Dosing and Efficacy in the Treatment of Cranial Hemorrhage in Hemophilia Patients with Inhibitors: An Analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004–2008).

Charles T Nakar, MD, David L. Cooper, MD, MBA, Donna DiMichele, MD

Blood (2008) 112 (11): 2278.

https://doi.org/10.1182/blood.V112.11.2278.2278

Published: 2008

NARROW

Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions

Safety & Efficacy of Human Plasma Derived Plasminogen Ophthalmic Drops for Treatment of Ligneous Conjunctivitis: Report of Phase 2/3 Clinical Trial

Prompt Immune Tolerance Induction at Inhibitor Diagnosis Regardless of Titer May Increase Overall Success in Hemophilia A With Inhibitors: Experience of Two US Centers

3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP. (Summary of 2 Pilot Studies).

Recombinant Activated Factor VII (rFVIIa) Dosing and Efficacy in the Treatment of Cranial Hemorrhage in Hemophilia Patients with Inhibitors: An Analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004–2008).

Email alerts

ASH Publications

American Society of Hematology

Pivotal Trial with Intravenous Plasminogen Replacement in Patients with Plasminogen Deficiency Demonstrates Long-Term Efficacy for Treatment and Prevention of Ligneous Lesions

Safety & Efficacy of Human Plasma Derived Plasminogen Ophthalmic Drops for Treatment of Ligneous Conjunctivitis: Report of Phase 2/3 Clinical Trial

Prompt Immune Tolerance Induction at Inhibitor Diagnosis Regardless of Titer May Increase Overall Success in Hemophilia A With Inhibitors: Experience of Two US Centers

3G8 and GMA161, Anti FcγRIII Inhibitory Monoclonal Antibodies in the Treatment of Chronic Refractory ITP. (Summary of 2 Pilot Studies).

Recombinant Activated Factor VII (rFVIIa) Dosing and Efficacy in the Treatment of Cranial Hemorrhage in Hemophilia Patients with Inhibitors: An Analysis of the Hemophilia and Thrombosis Research Society Registry (HTRS) (2004–2008).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only